Key result
Adolescents with congenital heart disease show no differences in menstrual patterns compared to healthy peers.
Why the study?
While reproductive concerns in adults with CHD are increasingly recognized, studies evaluating menstrual problems in adolescents with CHD remain limited.
Does congenital heart disease alter menstrual characteristics and related symptoms in adolescents compared to healthy peers?
Cross-Sectional (n=184)
No
Does congenital heart disease alter menstrual characteristics and related symptoms in adolescents compared to healthy peers?
Adolescents with congenital heart disease have menstrual characteristics largely comparable to healthy peers, though individualized counseling remains important, particularly for those on anticoagulants.
Comparable menstrual patterns in CHD adolescents support routine reassurance; leaves open symptom perception differences in cross-sectional data.
Objectives: As life expectancy increases in patients with congenital heart disease (CHD), providing appropriate gynecological care has become more important. While the gynecologic and reproductive health concerns of adults with CHD are increasingly recognized, studies focusing on menstrual problems in adolescents with CHD are limited. This study aimed to evaluate menstrual characteristics and related symptoms in adolescents with CHD. Methods: Adolescents aged 12-21 years who had experienced menarche at least two years earlier were included. The CHD group was classified as mild, moderate, or severe, and healthy adolescents served as controls. Menstrual histories were obtained from all participants. In the CHD group, additional clinical data (diagnosis, surgery/interventions, and medication use) were collected. Menstrual parameters were compared between the CHD and control groups, as well as across CHD subgroups. Results: A total of 108 adolescents with CHD (41 mild, 42 moderate, 25 severe) and 76 healthy controls were enrolled. No significant differences were found between groups in terms of age at menarche, menstrual cycle length, period duration, or daily pad use (p>0.05). Dysmenorrhea severity and frequency were similar; however, school absenteeism due to dysmenorrhea was significantly higher in the control group (p=0.037). Physical premenstrual symptoms-particularly bloating, anxiety, and mood swings-were more frequent in controls (p<0.05). Menstrual education rates from healthcare professionals were low in both groups. Conclusions: Our findings indicate that adolescents with CHD have menstrual characteristics comparable to those of healthy controls. However, despite these similarities, they may differ in their perception and tolerance of menstrual symptoms.
No takes yet. Share an insight, caveat, or question.
Arı et al. (2026) conducted a cross-sectional in Congenital heart disease (n=184). Congenital heart disease vs. Healthy adolescents was evaluated on Menstrual characteristics (age at menarche, menstrual cycle length, period duration, daily pad use) (p=>0.05). Adolescents with congenital heart disease exhibited menstrual characteristics comparable to healthy controls, with no significant differences in age at menarche, cycle length, or period duration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: